Lahontan Gold Corp
Commented by Lars Winter on November 6th, 2026 | 05:35 CET
Gold potential, pharma comeback and AI boom: Lahontan Gold, Bayer and AMD in Focus
A gold project with enormous return potential, a pharmaceutical group with fresh tailwinds and a chip designer on course for records: Lahontan Gold, Bayer and AMD are currently delivering exciting news. The leverage is particularly strong at the Canadian gold developer, whose Santa Fe project promises enormous growth potential according to the PEA. Bayer, meanwhile, recently raised its earnings targets, while AMD is benefiting from the expansion of data centres. We examine where the opportunities now lie and where investors need to look more closely - three interesting stocks under review.
Read
Commented by Stefan Feulner on November 3rd, 2026 | 05:29 CET
Kinross, Lahontan Gold and Agnico Eagle: Gold plunges as Nevada's mines come into focus
Gold is currently suffering a severe setback. On Friday, the price of an ounce fell below USD 3,900, reaching its lowest level in a year. Compared with its record high in January, the precious metal has lost around 30%. Rising interest rate expectations and selling pressure across equity markets are weighing on prices. This changes the equation for gold mining companies. While established producers continue to generate substantial cash inflows, developers must demonstrate that their projects remain attractive even at lower gold prices.
Read
Commented by Jens Castner on October 30th, 2026 | 05:45 CET
When the stock market gets it wrong: Schott Pharma clears its name; Lahontan Gold and Instone are the next candidates
Markets are quick to judge, and often paint companies with a broad brush. When one company runs into difficulties, its competitors immediately come under suspicion too. Schott Pharma has already been through this and dispelled the doubts with strong figures. Its share price is recovering. For Lahontan Gold and Instone Real Estate, the recovery has yet to come. The Canadian gold explorer is being punished alongside the major producers, while the property developer is being grouped with Berlin's residential landlords. In both cases, the facts tell a different story. The share price upside is considerable.
Read
Commented by Armin Schulz on October 29th, 2026 | 05:22 CET
Gold Stocks – Barrick Mining, Lahontan Gold and Newmont: Balancing Production Costs and Gold Prices
Barrick is set to report its third-quarter results on November 9, and the gold sector is heading into earnings season with favourable momentum. High gold prices boost producers' profits, provided they keep costs under control. The major producers are already benefiting from these conditions today. Developers can expect the economics of building new mines to improve. Strong demand for gold works in the industry's favour. To understand how companies are positioned in this environment, it is important to look at both operating mines and projects that have yet to be built. We therefore take a closer look at Barrick Mining, Lahontan Gold and Newmont.
Read
Commented by Stefan Bode on October 28th, 2026 | 05:25 CET
Taking advantage of politically driven markets, sell-offs and upturns: Lahontan Gold, Nu Holdings, OHB, Petrobras, Vale, Itaú Unibanco
Dynamic price surges, undiscovered value stocks and impulsive market reactions following political decisions are shaping current stock market activity. While a high-growth technology group faces key technical levels after a strong rally, a commodities explorer reveals enormous catch-up potential relative to its project value amid macroeconomic risks. At the same time, panic selling in Brazil is creating attractive contrarian entry opportunities.
Read
Commented by Nico Popp on October 26th, 2026 | 05:43 CET
Lahontan Gold, Kinross Gold and Barrick Mining: Strong Position in Nevada
The gold market is currently experiencing high volatility. The precious metal fell about 6% in a month and recently slipped below USD 4,000 per ounce for the first time since July. The long-term outlook remains robust according to a forecast by Goldman Sachs, with an expected price of USD 5,400 by the end of 2027. Against this backdrop, mining companies in Nevada are repositioning themselves. While established industry heavyweights are optimising their production, developers are advancing their projects towards production. One such company is Lahontan Gold.
Read
Commented by Fabian Lorenz on October 23rd, 2026 | 05:38 CEST
Strong News and Buy Recommendations: Vonovia, Evotec and Lahontan Gold
Strong news from Lahontan Gold. The explorer has published a positive preliminary economic assessment (PEA) for its Santa Fe gold-silver project in Nevada. The after-tax net present value stands at approximately USD 820 million, significantly exceeding the company's current market capitalisation. The company is also working to expand the resource base. While Lahontan Gold shareholders can look forward to the approaching start of gold production, Vonovia shareholders face an uncertain future. The expropriation scenario is weighing on sentiment. Even JPMorgan's assessment that these concerns are exaggerated does little to change the picture. In a worst-case scenario, the German government would intervene. And what about Evotec? The shares have gained more than 10% in recent trading days. The appointment of a new executive at Novo Nordisk could inject fresh momentum into the company.
Read
Commented by Carsten Mainitz on October 22nd, 2026 | 05:38 CEST
Gold and Concrete Gold: When Asset Values and Share Prices Diverge – Lahontan Gold, Vonovia and LEG Immobilien Under the Microscope
On the stock market, assets sometimes have two prices: a calculated or theoretical value and the current market price, reflected in the share price. When the gap between value and price becomes (too) wide, opportunities may arise for forward-looking investors. Or are these valuation discounts nothing more than a value trap? The latest developments at three companies give us reason to take a closer look. The newly published PEA, which provides an initial indication of the potential value of Lahontan Gold's gold project, values it at eight times (!) the Canadian company's market capitalisation. Real estate stocks have been among the market's laggards in recent months, weighed down by rising interest rates, economic concerns and political uncertainty. Even major players such as Vonovia have been affected. LEG's recent investment highlights how share price declines can create attractive valuation levels. So what does all this mean for investors?
Read
Commented by Tarik Dede on October 21st, 2026 | 05:33 CEST
Opportunities in Precious Metals: Lahontan Gold, First Majestic Silver and SSR Mining in Focus
In precious metals, the bulls have recently tried to push the price significantly higher again. However, this breakout attempt has failed for now. In the short term, the price, like that of silver, is moving in response to the latest statements by members of the Federal Reserve. Recently, an investment bank had also suggested that the US central bank could raise interest rates before the midterms in early November. This is weighing on prices. Yet the Fed has never raised interest rates before elections to signal political neutrality. The next meeting could be as early as next week. Accordingly, gold and silver are likely to remain highly volatile. For those with a long-term outlook, the currently subdued sentiment in the metals markets offers an opportunity to pick up promising shares. Today, we therefore look at the shares of Lahontan Gold, First Majestic Silver and SSR Mining.
Read
Commented by Lars Winter on October 20th, 2026 | 05:44 CEST
Gold, Money and Healthcare: Lahontan Gold, Goldman Sachs and Johnson & Johnson – 3 Promising Stocks Under Review
Canadian gold exploration company Lahontan Gold is generating optimism. A preliminary economic assessment of its key mining project in Nevada recently assigned the Santa Fe Mine a calculated project value of USD 820 million. This is a multiple of its current market capitalisation, giving the stock considerable upside potential. Goldman Sachs has also surprised the market in recent days with a strong set of financial results. Pharmaceutical giant Johnson & Johnson, meanwhile, raised its outlook despite one minor setback. Three promising companies with positive news are under review.
Read